1 unknown. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Unknown 1 |
Follow Ba Yi: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Study of Irinotecan Hydrochloride Liposome Combined With Capecitabine for Second-line Treatment in Patients With Advanced or Metastatic Biliary Tract Carcinoma irinotecan hydrochloride liposome injection, Capecitabine - Biliary Tract Carcinoma | Phase 2 | Unknown | Ba Yi | 20 | 2024-06-30 | 2024-05-28 |
Capecitabine (1)
China (1)
Yi Ba (1)